BioSpace News Archive

Biotech Beach

ThermoGenesis Announces Roll Out of ReadyStart cGMP Suites for Early-Stage Cell and Gene Therapy Companies

ThermoGenesis Holdings, Inc. announced that the Company is rolling out a new facility in the Sacramento metro area, containing a total of 12, class-7, ReadyStart cGMP Suites available for lease by early-stage life science and cell gene therapy companies.

March 15, 2023
·
4 min read
Drug Development

Sermonix Pharmaceuticals Announces E-Poster Presentation on I-SPY 2 Study of Neoadjuvant Lasofoxifene at St. Gallen International Breast Cancer Conference 2023

Sermonix Pharmaceuticals Inc. today presented an e-poster at the St. Gallen International Breast Cancer Conference detailing its Phase 2 clinical trial evaluating neoadjuvant lasofoxifene in molecularly selected HR+/HER2-, locally advanced breast cancer.

March 15, 2023
·
7 min read
Drug Development

Bridge Biotherapeutics to Present Updated Preclinical Data of BBT-207 at the AACR 2023 Annual Meeting

Bridge Biotherapeutics (KQ288330) announced that it is presenting a poster on its preclinical drug candidate BBT-207 at the American Association for Cancer Research (AACR) 2023 annual meeting taking place on April 14-19 in Orlando, Florida.

March 15, 2023
·
3 min read
Genetown

New Study Shows mRNA COVID-19 Vaccines Safe for Pregnant People: C-VIPER Pregnancy Registry Finds No Increased Risk of Spontaneous Abortion

CorEvitas, LLC (“CorEvitas”), a leading provider of syndicated registries, is pleased to share important safety information regarding mRNA COVID-19 vaccines and their use in pregnant people.

March 15, 2023
·
2 min read
argenx Announces UK MHRA Approval of VYVGART for the Treatment of Generalized Myasthenia Gravis

argenx (Euronext & Nasdaq: ARGX) today announced that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorization for VYVGART® (efgartigimod alfa-fcab) as an add-on to standard therapy for the treatment of adult patients with gMG who are AChR antibody positive1.

March 15, 2023
·
6 min read
Deals

Miltenyi Biotec acquires biosensor company lino Biotech

lino Biotech announced it has been acquired by Miltenyi Biotec, a global biotech company based in Germany, on February 22, 2023.

March 15, 2023
·
2 min read
Bio NC

NIH STUDY LINKS LOW BIRTHWEIGHT TO PRENATAL PER- AND POLYFLUOROALKYL SUBSTANCES (PFAS) EXPOSURE

High exposure to per- and polyfluoroalkyl substances (PFAS) during pregnancy may be associated with lower birthweights, according to a new study funded by Environmental influences on Child Health Outcomes Program (ECHO) at the National Institutes of Health.

March 15, 2023
·
2 min read
Deals

Werfen Completes Acquisition of Immucor, Inc., Expanding Leadership in Specialized Diagnostics

Werfen announced that it has successfully completed the acquisition of Immucor, Inc., after obtaining all necessary regulatory and antitrust approvals.

March 15, 2023
·
3 min read
Pharm Country

New economic analysis of Voraxaze® (glucarpidase) in patients with delayed methotrexate

BTG Pharmaceuticals, a SERB company, today announces the publication of an economic simulation assessing the value of Voraxaze® (glucarpidase) for treating adult patients in the United States who experience delayed methotrexate elimination due to impaired renal function.

March 15, 2023
·
6 min read
iOmx Therapeutics to Present Target Discovery Platform Myeloid iOTarg™ and New Data on SIK Checkpoint Inhibitor OMX-0407 at AACR 2023

iOmx Therapeutics AG today announced that its high-throughput target discovery platform, myeloid iOTargTM, will be highlighted in an oral presentation at the American Association for Cancer Research (AACR) Annual Meeting 2023.

March 15, 2023
·
4 min read